What are major issues for the 2nd year half in Korean drug market?

Published: 2018-08-07 08:43:36

Updated: 2018-08-07 08:43:36

Korea must be careful regarding exporting pharmaceutical products this year due to various aspects such as nullification of the Ecuadorian drug agreement and Indonesian ‘Protectionism.’

The KOTRA(Korea Trade-Investment Promotion Agency) analyzed and introduced the ‘Korea Import Control for 2018 First Half and Future Plans for Second Half’ report.

A section about drug-related issues in the rep...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.